معرفی
Robert N. Jamison is a Professor at Harvard Medical School holding joint appointments in the Departments of Anesthesiology, Psychiatry, and Physical Medicine and Rehabilitation. As a clinical psychologist primarily assigned to the Pain Management Center at Brigham and Women's Hospital, he directs research at the intersection of behavioral medicine and pain management with significant institutional affiliations across Harvard's medical ecosystem.
His research program systematically addresses three critical domains: psychological predictors of chronic pain outcomes, objective assessment of opioid misuse risk, and technological innovation in pain monitoring. This work produced clinically adopted instruments including the SOAPP-R and COMM for identifying patients requiring enhanced opioid monitoring, alongside foundational evidence on neuropsychological impacts of long-term opioid therapy that directly informs current pain management controversies.
Publication analysis reveals an evolutionary trajectory from psychometric validation of pain measurement tools (1990s) through opioid risk assessment frameworks (2000s) to contemporary digital health applications. His most influential works demonstrate how electronic diaries achieve near-perfect compliance through interactive features, establishing new standards for pain clinical trials while addressing the urgent need for objective opioid safety metrics.
Dr. Jamison's leadership includes principal investigator roles on multiple NIH-funded projects and editorial board positions for five prominent pain journals. His research team, currently comprising Limeng Wan as Research Assistant, operates within Brigham and Women's Hospital's Pain Management Center infrastructure, maintaining active collaborations with national pain organizations.
The interdisciplinary Pain Management Center research group integrates anesthesiology, psychiatry, and rehabilitation medicine perspectives while pioneering smartphone-based monitoring systems. Recent work focuses on identifying patient subgroups most likely to benefit from digital interventions, positioning the team at the vanguard of personalized pain management technology implementation.
